Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Cunningham

Showing results (41-50 of 621) with videos related to

Pageof 63
Sort By:
Lancet (London, England)|June 8, 2021
Chemotherapy with nivolumab in advanced gastro-oesophageal adenocarcinomaCaroline Fong, David Cunningham
Education for Primary Care : an Official Publication of the Association of Course Organisers, National Association of GP Tutors, World Organisation of Family Doctors|October 4, 2019
Accepting or rejecting qualitative education research: what are our expectations as editors?Sam Scallan, David Cunningham
Nature Clinical Practice. Oncology|February 7, 2008
Does combining docetaxel with cisplatin and fluorouracil improve clinical benefit in advanced gastroesophageal cancer?Gihan Ratnayake, David Cunningham
Current Treatment Options in Oncology|November 17, 2017
The Role of Systemic Therapy in Resectable Gastric and Gastro-oesophageal Junction CancerElizabeth Cartwright, David Cunningham
European Journal of Cancer (Oxford, England : 1990)|August 1, 2009
Current perspective: bevacizumab in colorectal cancer--a time for reappraisal?Alicia Okines, David Cunningham
The Lancet. Oncology|November 6, 2010
Are we ready to restrict EGFR therapy to quadruple-negative colorectal cancer?Eliza Hawkes, David Cunningham
The Lancet. Oncology|August 5, 2014
Cetuximab or bevacizumab in metastatic colorectal cancer?Francesco Sclafani, David Cunningham
Clinical Colorectal Cancer|April 12, 2008
A retrospective on the inhibition of epidermal growth factor receptor as a therapeutic strategy for patients with relapsed metastatic colorectal cancer: impact on treatment of today's patientsChristopher Jackson, David Cunningham
Journal of Geriatric Oncology|February 4, 2014
Bevacizumab in elderly patients with metastatic colorectal cancerFrancesco Sclafani, David Cunningham
Nature Reviews. Clinical Oncology|August 28, 2010
Flexible sigmoidoscopy--valuable in colorectal cancerEliza A Hawkes, David Cunningham
Pageof 63

Showing results (41-50 of 621) with videos related to

Sort By:
Pageof 63
Lancet (London, England)|June 8, 2021
Chemotherapy with nivolumab in advanced gastro-oesophageal adenocarcinomaCaroline Fong, David Cunningham
Education for Primary Care : an Official Publication of the Association of Course Organisers, National Association of GP Tutors, World Organisation of Family Doctors|October 4, 2019
Accepting or rejecting qualitative education research: what are our expectations as editors?Sam Scallan, David Cunningham
Nature Clinical Practice. Oncology|February 7, 2008
Does combining docetaxel with cisplatin and fluorouracil improve clinical benefit in advanced gastroesophageal cancer?Gihan Ratnayake, David Cunningham
Current Treatment Options in Oncology|November 17, 2017
The Role of Systemic Therapy in Resectable Gastric and Gastro-oesophageal Junction CancerElizabeth Cartwright, David Cunningham
European Journal of Cancer (Oxford, England : 1990)|August 1, 2009
Current perspective: bevacizumab in colorectal cancer--a time for reappraisal?Alicia Okines, David Cunningham
The Lancet. Oncology|November 6, 2010
Are we ready to restrict EGFR therapy to quadruple-negative colorectal cancer?Eliza Hawkes, David Cunningham
The Lancet. Oncology|August 5, 2014
Cetuximab or bevacizumab in metastatic colorectal cancer?Francesco Sclafani, David Cunningham
Clinical Colorectal Cancer|April 12, 2008
A retrospective on the inhibition of epidermal growth factor receptor as a therapeutic strategy for patients with relapsed metastatic colorectal cancer: impact on treatment of today's patientsChristopher Jackson, David Cunningham
Journal of Geriatric Oncology|February 4, 2014
Bevacizumab in elderly patients with metastatic colorectal cancerFrancesco Sclafani, David Cunningham
Nature Reviews. Clinical Oncology|August 28, 2010
Flexible sigmoidoscopy--valuable in colorectal cancerEliza A Hawkes, David Cunningham
Pageof 63